You have 9 free searches left this month | for more free features.

Carcinosarcoma

Showing 26 - 50 of 111

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +10 more
  • Bevacizumab
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Ovarian Cancer, Carcinosarcoma Trial (Pamiparib)

Withdrawn
  • Ovarian Cancer
  • Carcinosarcoma
  • (no location specified)
Aug 3, 2021

Breast Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Philadelphia (Metformin

Active, not recruiting
  • Breast Carcinoma
  • +4 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Feb 28, 2022

Endometrial Cancer, Carcinosarcoma Trial in United States (ZW25)

Recruiting
  • Endometrial Cancer
  • Carcinosarcoma
  • Basking Ridge, New Jersey
  • +6 more
Jan 11, 2022

Stage I Testicular Seminoma, Stage I Testicular Nonseminomatous Germ Cell Tumor, Gastrointestinal Stromal Tumors Trial in

Not yet recruiting
  • Stage I Testicular Seminoma
  • +13 more
  • Oncological Follow-up
  • Amiens, France
  • +2 more
Aug 12, 2022

Carcinosarcoma of Ovary, Carcinosarcoma of Uterus, Carcinosarcoma of Vagina Trial in Birmingham (Cabozantinib, Ipilimumab,

Withdrawn
  • Carcinosarcoma of Ovary
  • +2 more
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 18, 2021

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Folate Receptor Alpha Positive Trial in Columbus (other, biological, drug)

Active, not recruiting
  • BRCA1 Gene Mutation
  • +9 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Endometrial Cancer, Uterine Carcinosarcoma Trial in New York, Bethlehem, Milwaukee (Rucaparib, Bevacizumab, Atezolizumab)

Active, not recruiting
  • Endometrial Cancer
  • Uterine Carcinosarcoma
  • New York, New York
  • +2 more
Apr 4, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma Trial in

Recruiting
  • Fallopian Tube Carcinosarcoma
  • +28 more
  • Pegylated Liposomal Doxorubicin Hydrochloride
  • Peposertib
  • Aurora, Colorado
  • +7 more
Sep 2, 2022

Uterine Cancer, Endometrial Carcinoma, Carcinosarcoma Trial in United States (Nivolumab)

Active, not recruiting
  • Uterine Cancer
  • +6 more
  • Basking Ridge, New Jersey
  • +7 more
Apr 4, 2022

MSI-H Colorectal Cancer, Melanoma, Anal Carcinoma Trial in Spain (Spartalizumab)

Active, not recruiting
  • MSI-H Colorectal Cancer
  • +30 more
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022

Stage IA Uterine Sarcoma, Stage IB Uterine Sarcoma, Stage IC Uterine Sarcoma Trial in Bronx (drug, radiation, other)

Terminated
  • Stage IA Uterine Sarcoma
  • +10 more
  • Bronx, New York
    Albert Einstein College of Medicine
Apr 21, 2021

Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma Trial in

Active, not recruiting
  • Endometrial Adenosquamous Carcinoma
  • +9 more
  • Cabozantinib S-malate
  • +2 more
  • Duarte, California
  • +18 more
Oct 15, 2022

Carcinosarcoma, Endometrial Tumors Trial in United Kingdom (Paclitaxel, Cediranib, Olaparib)

Active, not recruiting
  • Carcinosarcoma
  • Endometrial Neoplasms
  • Northwood, Middlesex, United Kingdom
  • +14 more
Feb 10, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Ovarian Brenner Tumor, Ovarian Carcinosarcoma, Ovarian Clear Cell Cystadenocarcinoma Trial in Canada, Singapore, United States

Active, not recruiting
  • Ovarian Brenner Tumor
  • +11 more
  • Duarte, California
  • +15 more
Aug 11, 2022

Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)

Recruiting
  • Bone Sarcoma
  • +15 more
  • Aldesleukin
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 3, 2022

Endometrioid Adenocarcinoma, Serous Carcinoma, Clear Cell Carcinoma Trial in London (Image-guided adjuvant pelvic radiotherapy)

Recruiting
  • Endometrioid Adenocarcinoma
  • +4 more
  • Image-guided adjuvant pelvic radiotherapy
  • London, Ontario, Canada
    London Regional Cancer Program
Sep 2, 2020

Leiomyosarcoma or Carcinosarcoma Trial in Germany (Pazopanib plus Gemcitabine, Pazopanib)

Recruiting
  • Leiomyosarcoma or Carcinosarcoma
  • Bad Saarow, Germany
  • +8 more
Nov 27, 2020

The Immune Landscape of Epithelial Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • Collection of tumor samples, blood and vaginal and rectal swabs
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland
Aug 2, 2023

Leiomyosarcoma, Endometrial Stromal Tumors, Carcinosarcomas Uterine Trial in Graz (Vorinostat Oral Capsule)

Terminated
  • Leiomyosarcoma
  • +2 more
  • Vorinostat Oral Capsule
  • Graz, Austria
    Medical University of Graz, Clinic of Obstetrics and Gynecology
Jul 27, 2020

Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

Completed
  • Fallopian Tube Carcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +22 more
Oct 19, 2021

Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus Trial in Philadelphia (Radiotherapy)

Completed
  • Carcinoma of the Cervix, Carcinoma or Carcinosarcoma of the Uterus
  • Radiotherapy
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Nov 25, 2019

Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma Trial in Philadelphia (Laboratory Biomarker Analysis, Thalidomide)

Completed
  • Recurrent Uterine Corpus Sarcoma
  • Uterine Carcinosarcoma
  • Philadelphia, Pennsylvania
    Gynecologic Oncology Group
Jul 22, 2019

Endometrial Carcinoma, Stage 0 Fallopian Tube Cancer AJCC v7, Stage I Fallopian Tube Cancer AJCC v6 and v7 Trial in New

Withdrawn
  • Endometrial Carcinoma
  • +55 more
  • Internet-Based Intervention
  • +3 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Apr 16, 2021